Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger B-box domain-containing protein 1 (ZBBX) is a protein encoded in humans by the ZBBX gene[4][6]. Its defining feature is the B-box-type zinc finger domain, a structural motif that typically binds two zinc ions and is involved in protein–protein interactions, rather than direct DNA interaction, unlike some other zinc finger proteins[1][2][3][6]. B-box domains are found in a wide variety of proteins, including many transcription factors and structural regulators, but ZBBX itself has not been specifically classified as a receptor, enzyme, transporter, or established therapeutic target[4][6]. Though some zinc finger B-box domain proteins play major regulatory roles, direct involvement of ZBBX in signaling pathways or as a clinical drug target has not been established. An association with "polyneuropathy due to drug" is reported as a disease link, but the details and strength of this association remain unspecified[4]. No curated drugs, biomarkers, or mechanism-of-action data for ZBBX in disease or therapy are available as of now.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger B-box domain-containing protein 1 (ZBBX).